HDAC inhibitors such as trichostatin (TSA), suberoylanilide hydroxamic acid (SAHA, also known as Vorinostat), and apicidin upregulated expressions of PLD2 in MDA-MB 231 and MDA-MB435 breast cancer cells as determined by q-PCR (Fig. 1a). Here, HDAC9 is linked to breast carcinoma.